Guo W, Tao Y, Yang R, Mao K, Zhou H, Xu M
Sci Adv. 2024; 10(46):eadq2899.
PMID: 39536102
PMC: 11559619.
DOI: 10.1126/sciadv.adq2899.
Brogna C, Cristoni S, Petrillo M, Bisaccia D, Lauritano F, Montano L
F1000Res. 2024; 11:135.
PMID: 39464247
PMC: 11502994.
DOI: 10.12688/f1000research.77421.2.
Li Y, Lu S, Wang J, Yao H, Liang L
Heliyon. 2024; 10(12):e33179.
PMID: 39021908
PMC: 11253070.
DOI: 10.1016/j.heliyon.2024.e33179.
Almulla N, Soltane R, Alasiri A, Kamal Allayeh A, Alqadi T, Alshehri F
Heliyon. 2024; 10(9):e29909.
PMID: 38707469
PMC: 11068538.
DOI: 10.1016/j.heliyon.2024.e29909.
Kim Y, Min J
Nano Converg. 2024; 11(1):3.
PMID: 38206526
PMC: 10784265.
DOI: 10.1186/s40580-023-00410-5.
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations.
Shaprova O, Shanshin D, Kolosova E, Borisevich S, Soroka A, Merkuleva I
Antibodies (Basel). 2023; 12(4).
PMID: 38131804
PMC: 10741209.
DOI: 10.3390/antib12040082.
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection.
Wang L, Patrone P, Kearsley A, Izac J, Gaigalas A, Prostko J
Int J Mol Sci. 2023; 24(21).
PMID: 37958688
PMC: 10650176.
DOI: 10.3390/ijms242115705.
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature.
Cantoni D, Wilkie C, Bentley E, Mayora-Neto M, Wright E, Scott S
Front Immunol. 2023; 14:1184362.
PMID: 37790941
PMC: 10544934.
DOI: 10.3389/fimmu.2023.1184362.
Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases.
Soto J, Linsley C, Song Y, Chen B, Fang J, Neyyan J
Nanomaterials (Basel). 2023; 13(17).
PMID: 37686965
PMC: 10490511.
DOI: 10.3390/nano13172455.
Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study.
Montes-Herrera D, Munoz-Medina J, Fernandes-Matano L, Salas-Lais A, Hernandez-Cueto M, Santacruz-Tinoco C
Diagnostics (Basel). 2023; 13(16).
PMID: 37627889
PMC: 10453006.
DOI: 10.3390/diagnostics13162630.
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.
Williams D, Hornsby H, Shehata O, Brown R, Gallis M, Meardon N
iScience. 2023; 26(7):107056.
PMID: 37346049
PMC: 10246304.
DOI: 10.1016/j.isci.2023.107056.
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
Goffin E, Du X, Hemmi S, Machiels B, Gillet L
J Virol. 2023; 97(7):e0013523.
PMID: 37338377
PMC: 10373536.
DOI: 10.1128/jvi.00135-23.
SERS Signature of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs: Towards Perspective COVID-19 Point-of-Care Diagnostics.
Berus S, Nowicka A, Wieruszewska J, Nicinski K, Kowalska A, Szymborski T
Int J Mol Sci. 2023; 24(11).
PMID: 37298658
PMC: 10253828.
DOI: 10.3390/ijms24119706.
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study.
Kemp T, Hempel H, Pan Y, Roy D, Cherry J, Lowy D
Microbiol Spectr. 2023; 11(3):e0535322.
PMID: 37191544
PMC: 10269912.
DOI: 10.1128/spectrum.05353-22.
Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing.
Carrell C, Jang I, Link J, Terry J, Call Z, Panraksa Y
Anal Methods. 2023; 15(22):2721-2728.
PMID: 37099406
PMC: 10249653.
DOI: 10.1039/d3ay00225j.
Adherence of healthcare workers to COVID-19 infection prevention practices and its relationship with SARS-CoV-2 seropositivity.
El-Ghitany E, Ashour A, Elmorshedy H, Farghaly A, Hashish M, Omran E
J Infect Prev. 2023; 24(3):119-131.
PMID: 37051305
PMC: 9988594.
DOI: 10.1177/17571774231158782.
At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study.
Wigren Bystrom J, Vikstrom L, Rosendal E, Groning R, Gwon Y, Nilsson E
Euro Surveill. 2023; 28(13).
PMID: 36995373
PMC: 10064644.
DOI: 10.2807/1560-7917.ES.2023.28.13.2200432.
Sensitivity-enhanced nanoplasmonic biosensor using direct immobilization of two engineered nanobodies for SARS-CoV-2 spike receptor-binding domain detection.
Ma Z, Sun Z, Lv X, Chen H, Geng Y, Geng Z
Sens Actuators B Chem. 2023; 383:133575.
PMID: 36873859
PMC: 9957344.
DOI: 10.1016/j.snb.2023.133575.
A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs.
Diezma-Diaz C, Alvarez-Garcia G, Regidor-Cerrillo J, Miro G, Villanueva-Saz S, Perez M
Front Vet Sci. 2023; 10:1121935.
PMID: 36777670
PMC: 9909348.
DOI: 10.3389/fvets.2023.1121935.
Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
Takahashi M, Saito K, Ai T, Nojiri S, Khasawneh A, Paran F
PLoS One. 2023; 18(1):e0279779.
PMID: 36693058
PMC: 9873150.
DOI: 10.1371/journal.pone.0279779.
